Clinical Trial Update: Clinical Trial of Idebenone in Primary Progressive Multiple Sclerosis (IPPoMS) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of idebenone for primary progressive multiple sclerosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• Idebenone (idebenone)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Primary Progressive Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-03-07